OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies
Girish Chandra Arya, Kamalpreet Kaur, Vikas Jaitak
European Journal of Medicinal Chemistry (2021) Vol. 221, pp. 113511-113511
Closed Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors
Ulviye Acar Çevik, İsmail Çeli̇k, Ayşen Işık, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 5, pp. 1944-1958
Closed Access | Times Cited: 60

A review of recent synthetic strategies and biological activities of isoxazole
Chandrashekhar P. Pandhurnekar, Himani C. Pandhurnekar, Arvind J. Mungole, et al.
Journal of Heterocyclic Chemistry (2022) Vol. 60, Iss. 4, pp. 537-565
Closed Access | Times Cited: 53

Design, synthesis, in vitro anticancer and antimicrobial evaluation, SAR analysis, molecular docking and dynamic simulation of new pyrazoles, triazoles and pyridazines based isoxazole
Hyam A. Radwan, Iqrar Ahmad, Ismail M. M. Othman, et al.
Journal of Molecular Structure (2022) Vol. 1264, pp. 133312-133312
Closed Access | Times Cited: 52

Isoxazole/Isoxazoline Skeleton in the Structural Modification of Natural Products: A Review
Xiyue Wang, Qingyun Hu, Hui Tang, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 228-228
Open Access | Times Cited: 24

Incredible use of plant-derived bioactives as anticancer agents
Kiran Kangra, Saloni Kakkar, Vineet Mittal, et al.
RSC Advances (2025) Vol. 15, Iss. 3, pp. 1721-1746
Open Access

Selenium-Containing Agents Acting on Cancer—A New Hope?
Sabrina Garbo, Silvia Di Giacomo, Dorota Łażewska, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 104-104
Open Access | Times Cited: 28

Design, synthesis and bioactivity of myricetin derivatives for control of fungal disease and tobacco mosaic virus disease
Xiao Cao, Bangcan He, Fang Liu, et al.
RSC Advances (2023) Vol. 13, Iss. 10, pp. 6459-6465
Open Access | Times Cited: 15

In silico anticancer activity of isoxazolidine and isoxazolines derivatives: DFT study, ADMET prediction, and molecular docking
Moulay Driss Mellaoui, Khadija Zaki, Khalid Abbiche, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 138330-138330
Closed Access | Times Cited: 4

A Brief Review on the Synthesis of 4H‐Chromene‐Embedded Heterocycles
K. Nissi Sharon, P. Padmaja, Pedavenkatagari Narayana Reddy
ChemistrySelect (2024) Vol. 9, Iss. 27
Closed Access | Times Cited: 4

The In Vitro Impact of Isoxazole Derivatives on Pathogenic Biofilm and Cytotoxicity of Fibroblast Cell Line
Urszula Bąchor, Adam Junka, Malwina Brożyna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2997-2997
Open Access | Times Cited: 12

Design, synthesis, In-vitro, In-silico and DFT studies of novel functionalized isoxazoles as antibacterial and antioxidant agents
Aziz Arzine, Oussama Abchır, Mohammed Chalkha, et al.
Computational Biology and Chemistry (2023) Vol. 108, pp. 107993-107993
Closed Access | Times Cited: 12

Design, synthesis, X-ray crystal structures, anticancer, DNA binding, and molecular modelling studies of pyrazole–pyrazoline hybrid derivatives
Manish Rana, Hungharla Hungyo, Palak Parashar, et al.
RSC Advances (2023) Vol. 13, Iss. 38, pp. 26766-26779
Open Access | Times Cited: 11

Identification of 1,3,4-oxadiazoles as tubulin-targeted anticancer agents: a combined field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, molecular dynamics simulation, and density functional theory calculation approach
Agnidipta Das, Manaswini Sarangi, Kailash Jangid, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 19, pp. 10323-10341
Closed Access | Times Cited: 11

Transition Metal‐Mediated Functionalization of Isoxazoles: A Review
Suchithra Madhavan, Santosh Kumar Keshri, Manmohan Kapur
Asian Journal of Organic Chemistry (2021) Vol. 10, Iss. 12, pp. 3127-3165
Closed Access | Times Cited: 30

Structural Evidence for Aromatic Heterocycle N–O Bond Activation via Oxidative Addition
Michael K. Bogdos, Patrick Müller, Bill Morandi
Organometallics (2023) Vol. 42, Iss. 3, pp. 211-217
Open Access | Times Cited: 10

Synthesis, in-vitro inhibition of cyclooxygenases and in silico studies of new isoxazole derivatives
Waqas Alam, Haroon Khan, Muhammad Saeed Jan, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 10

Green chemistry approach towards Piperazine: anticancer agents
Vishal Sharma, Rina Das, Diksha Sharma, et al.
Journal of Molecular Structure (2023) Vol. 1292, pp. 136089-136089
Closed Access | Times Cited: 9

Electrochemical assembly of isoxazoles via a four-component domino reaction
Yuanyuan Zhao, Xinyue Li, Simon L. Homölle, et al.
Chemical Science (2023) Vol. 15, Iss. 3, pp. 1117-1122
Open Access | Times Cited: 9

Synthesis of novel sulphamethoxazole derivatives and exploration of their anticancer and antimicrobial properties
Rita Vaickelionienė, Vilma Petrikaitė, Irena Vaškevičienė, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0283289-e0283289
Open Access | Times Cited: 8

An insight into thymidylate synthase inhibitor as anticancer agents: an explicative review
Aratrika Sen, Dipanjan Karati
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5437-5448
Closed Access | Times Cited: 2

New Synthesis of Some Isoxazole Derivatives and Their Antioxidant Properties
Nesimi Uludağ
Russian Journal of Organic Chemistry (2024) Vol. 60, Iss. 3, pp. 490-494
Closed Access | Times Cited: 2

Targeting hematological malignancies with isoxazole derivatives
Monika Majirská, Martina Bago Pilátová, Z Kudlicková, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104059-104059
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top